Abadi Lestari’s Net Profit Rises 19.14% in Third Quarter of 2026
Jakarta, CNBC Indonesia — PT Abadi Lestari Indonesia Tbk (RLCO) recorded a 19.14% increase in net profit for the period to Rp24.09 billion in the first nine months of 2026. The result underscores the company’s success in implementing operational efficiency measures through digitalisation and production cost controls.
President Director Edwin Pranata said cost control had been a key factor in sustaining the company’s profitability.
“Amid market dynamics and adjustments in demand, we continue to work to maintain performance through more effective cost management,” Edwin said, according to a written statement on Wednesday (4 November 2026).
The efficiency measures were reflected in an 8.06% year-on-year fall in cost of goods sold to Rp339.19 billion from Rp368.93 billion in the same period a year earlier.
According to its consolidated financial statements as at 30 September 2026, RLCO recorded sales of Rp424.59 billion, compared with Rp448.13 billion in the same period last year. By business segment, processed swiftlet nest products remained the main contributor, with sales of Rp379.19 billion, equivalent to 89.3% of total sales.
Consumer products contributed Rp45.40 billion, or around 10.7%, with a gross profit margin of 46.4%, up on the same period a year earlier.
Gross profit consequently rose 7.83% year on year to Rp85.41 billion from Rp79.20 billion. The gross margin increased to 20.1% from 17.7% in the first nine months of 2025. The largest improvement was in processed swiftlet nest products, where the gross margin rose from 13.9% to 17.0%.
The improved profitability was in line with efficiency measures across several cost items. The company reported savings of around Rp28.5 billion.
These efficiencies also helped raise the operating margin to 15.3%, from 12.7% in the previous comparable period.
The company is also continuing to diversify its business by developing its consumer product portfolio, including Momiku and Realfood Reserve. The move forms part of its strategy to develop higher value-added products and broaden its revenue sources, while retaining processed swiftlet nest products as its main sales contributor.
On product development, RLCO continued research and testing on bioactive phytopharmaceutical products. The company spent Rp10.14 billion on these development activities in the first nine months of 2026.
On the balance sheet, RLCO’s total assets stood at Rp838.68 billion as at 30 September 2026. Total liabilities amounted to Rp509.25 billion, while the company’s total equity was Rp329.43 billion.
Source: jawawa.id (https://jawawa.id/newsitem/abadi-lestaris-net-profit-rises-19-14-in-third-quarter-of-2026-1793767826)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/market/20261104110704-17-782165/top-laba-bersih-abadi-lestari-tumbuh-1914-di-kuartal-iii-2026), translated from Indonesian